7.36 USD
▼-0.12-1.60%
盘后 7.97 0.00%
2026-09-15
市值
$6.64B
市盈率
12.85
EPS
0.75
股息率
1.17%
52 周区间
6.96 – 10.23
成交量
590.61K
Beta
1.19
目标价
10.87
52W 低 6.9652W 高 10.23
价格走势
公司简介
Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as wel...